XLRN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases...

Stats
Dagens volum	7.88M
Gjennomsnittsvolum	1.27M
Markedsverdi	0.00
EPS	$-1.160 ( 2021-11-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$2.64 (1.48%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-19	Zakrzewski Joseph S	Sell	34 499	Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	10 000	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	7 500	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	7 500	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	10 000	Option to Purchase Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 155 406 \| Sell: 743 673

Volum Korrelasjon

Lang: 0.40 (neutral)

Kort: 0.62 (weak)

Signal:(71.182) Neutral

Acceleron Pharma Inc Korrelasjon

10 Mest positive korrelasjoner
APAC	0.971
THCPU	0.97
WTMA	0.97
ALGN	0.966
CRUS	0.963
ALGM	0.961
ATRS	0.961
IQ	0.96
NVAC	0.96
BLDR	0.959

10 Mest negative korrelasjoner
NAKD	-0.958
PROC	-0.953
MTEX	-0.949
AHPI	-0.949
GRIN	-0.946
TRIT	-0.94
PIII	-0.938
LCAP	-0.935
CYTO	-0.935
LAWS	-0.934

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Acceleron Pharma Inc Korrelasjon - Valuta/Råvare

0.97
( very strong )

0.94
( very strong )

-0.78
( moderate negative )

0.86
( strong )

0.44
( neutral )

-0.64
( weak negative )

Acceleron Pharma Inc Økonomi

Annual	2020
Omsetning:	$92.52M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.92

FY	2020
Omsetning:	$92.52M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.92

FY	2019
Omsetning:	$73.99M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.38

FY	2018
Omsetning:	$13.99M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.59

Financial Reports:

No articles found.

Acceleron Pharma Inc

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers luspatercept-aamt for the treatment of anemia in adult patients with beta-thalassemia under the REBLOZYL name. The company also develops luspatercept-aamt for the treatment of myelodysplastic syndromes and myelofibrosis; Sotatercept for the treatment of patients with pulmonary arterial hypertension; and ACE-083, a neuromuscular candidate that is in Phase II clinical trials for the treatment of patients with Charcot-Marie-Tooth disease. In addition, it has a collaboration, license, and option agreement with Celgene Corporation; and collaboration and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.